메뉴 건너뛰기




Volumn 30, Issue 7, 2010, Pages 3045-3049

Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer

Author keywords

Artery; Colorectal cancer; Doxifluridine; Irinotecan; Liver metastases; Oxaliplatin

Indexed keywords

ANTIEMETIC AGENT; ANTIINFLAMMATORY AGENT; ATROPINE; DOXIFLURIDINE; FOLINIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IODINATED POPPYSEED OIL; IRINOTECAN; LOPERAMIDE; OXALIPLATIN; SEROTONIN AGONIST;

EID: 77955805623     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (13)

References (23)
  • 1
    • 34147128086 scopus 로고    scopus 로고
    • Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery
    • DOI 10.1097/01.sla.0000250453.34507.d3, PII 0000065820070400000014
    • Xu J, Zhong Y, Weixin N, Xinyu Q, Yanhan L, Li R, Jianhua W, Zhiping Y and Jiemin C: Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery. Ann Surg 245: 583-590, 2007. (Pubitemid 46555662)
    • (2007) Annals of Surgery , vol.245 , Issue.4 , pp. 583-590
    • Xu, J.1    Zhong, Y.2    Weixin, N.3    Xinyu, Q.4    Yanhan, L.5    Li, R.6    Jianhua, W.7    Zhiping, Y.8    Jiemin, C.9
  • 2
    • 13444274825 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases
    • DOI 10.1016/j.ejso.2004.07.030, PII S0748798304001970
    • Yedibela S, Elad L, Wein A, Dimmler A, Merkel S, Hohenberger W and Meyer T: Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases. Eur J Surg Oncol 31: 141-146, 2005. (Pubitemid 40214748)
    • (2005) European Journal of Surgical Oncology , vol.31 , Issue.2 , pp. 141-146
    • Yedibela, S.1    Elad, L.2    Wein, A.3    Dimmler, A.4    Merkel, S.5    Hohenberger, W.6    Meyer, T.7
  • 3
    • 70249110476 scopus 로고    scopus 로고
    • Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients
    • de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L and Pawlik TM: Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250: 440-448, 2009.
    • (2009) Ann Surg , vol.250 , pp. 440-448
    • De Jong, M.C.1    Pulitano, C.2    Ribero, D.3    Strub, J.4    Mentha, G.5    Schulick, R.D.6    Choti, M.A.7    Aldrighetti, L.8    Capussotti, L.9    Pawlik, T.M.10
  • 8
    • 2342469841 scopus 로고    scopus 로고
    • Efficacy of treatment with irinotecan and oxaliplatin combination in FU-resistant metastatic colorectal cancer patients
    • DOI 10.1159/000077439
    • Bajetta E, Beretta E, Di Bartolomeo M, Cortinovis D, Ferrario E, Dognini G, Toffolatti L and Buzzoni R: Efficacy of treatment with irinotecan and oxaliplatin combination in FU-resistant metastatic colorectal cancer patients. Oncology 66: 132-137, 2004. (Pubitemid 38608380)
    • (2004) Oncology , vol.66 , Issue.2 , pp. 132-137
    • Bajetta, E.1    Beretta, E.2    Di Bartolomeo, M.3    Cortinovis, D.4    Ferrario, E.5    Dognini, G.6    Toffolatti, L.7    Buzzoni, R.8
  • 9
    • 63449115959 scopus 로고    scopus 로고
    • Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer
    • Cao W, Yang W, Lou G, Jiang J, Geng M, Xi W, Li H, Ma T and Jin Y: Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer. Anticancer Drugs 20: 287-293, 2009.
    • (2009) Anticancer Drugs , vol.20 , pp. 287-293
    • Cao, W.1    Yang, W.2    Lou, G.3    Jiang, J.4    Geng, M.5    Xi, W.6    Li, H.7    Ma, T.8    Jin, Y.9
  • 12
    • 70249149719 scopus 로고    scopus 로고
    • Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
    • Kemeny NE, Melendez FD, Capanu M, Paty PB, Fong Y, Schwartz LH, Jarnagin WR, Patel D and D'Angelica M: Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 27: 3465-3471, 2009.
    • (2009) J Clin Oncol , vol.27 , pp. 3465-3471
    • Kemeny, N.E.1    Melendez, F.D.2    Capanu, M.3    Paty, P.B.4    Fong, Y.5    Schwartz, L.H.6    Jarnagin, W.R.7    Patel, D.8    D'Angelica, M.9
  • 13
    • 67650354362 scopus 로고    scopus 로고
    • Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
    • Kemeny N, Capanu M, D'Angelica M, Jarnagin W, Haviland D, Dematteo R and Fong Y: Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann Oncol 20: 1236-1241, 2009.
    • (2009) Ann Oncol , vol.20 , pp. 1236-1241
    • Kemeny, N.1    Capanu, M.2    D'Angelica, M.3    Jarnagin, W.4    Haviland, D.5    Dematteo, R.6    Fong, Y.7
  • 16
    • 0036844353 scopus 로고    scopus 로고
    • Hepatic artery chemotherapy for colorectal liver metastases: Technical considerations and review of clinical trials
    • Skitzki JJ and Chang AE: Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials. Surg Oncol 11: 123-135, 2002.
    • (2002) Surg Oncol , vol.11 , pp. 123-135
    • Skitzki, J.J.1    Chang, A.E.2
  • 17
    • 0345447199 scopus 로고    scopus 로고
    • An update on hepatic arterial infusion chemotherapy for colorectal cancer
    • Cohen AD and Kemeny NE: An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 5: 553-566, 2003.
    • (2003) Oncologist , vol.5 , pp. 553-566
    • Cohen, A.D.1    Kemeny, N.E.2
  • 18
    • 0036928276 scopus 로고    scopus 로고
    • Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: A dose-finding study in patients with advanced gastrointestinal malignancies
    • Comella P, Casaretti R, De Rosa V, Avallone A, Izzo F, Fiore F, Lapenta L and Comella G: Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies. Ann Oncol 13: 1874-1881, 2002.
    • (2002) Ann Oncol , vol.13 , pp. 1874-1881
    • Comella, P.1    Casaretti, R.2    De Rosa, V.3    Avallone, A.4    Izzo, F.5    Fiore, F.6    Lapenta, L.7    Comella, G.8
  • 19
    • 33645309877 scopus 로고    scopus 로고
    • FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs. FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): A multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
    • Souglakos J, Androulakis N, Syrigos K, Polyzos A, Ziras N, Athanasiadis A, Kakolyris S, Tsousis S, Kouroussis Ch, Vamvakas L, Kalykaki A, Samonis G, Mavroudis D and Georgoulias V: FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs. FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG). Br J Cancer 94: 798-805, 2006.
    • (2006) Br J Cancer , vol.94 , pp. 798-805
    • Souglakos, J.1    Androulakis, N.2    Syrigos, K.3    Polyzos, A.4    Ziras, N.5    Athanasiadis, A.6    Kakolyris, S.7    Tsousis, S.8    Kouroussis, Ch.9    Vamvakas, L.10    Kalykaki, A.11    Samonis, G.12    Mavroudis, D.13    Georgoulias, V.14
  • 23
    • 57049164995 scopus 로고    scopus 로고
    • Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy
    • Nobili S, Checcacci D, Filippelli F, Del Buono S, Mazzocchi V, Mazzei T and Mini E: Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy. J Chemother 20: 622-631, 2008.
    • (2008) J Chemother , vol.20 , pp. 622-631
    • Nobili, S.1    Checcacci, D.2    Filippelli, F.3    Del Buono, S.4    Mazzocchi, V.5    Mazzei, T.6    Mini, E.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.